Traumatic injury of the central nervous system (CNS) including brain and spinal cord remains a leading cause of morbidity and disability in the world. Delineating the mechanisms underlying the secondary and persistent injury versus the primary and transient injury has been drawing extensive attention for study during the past few decades. The sterile neuroinflammation during the secondary phase of injury has been frequently identified substrate underlying CNS injury, but as of now, no conclusive studies have determined whether this is a beneficial or detrimental role in the context of repair. Recent pioneering studies have demonstrated the key roles for the innate and adaptive immune responses in regulating sterile neuroinflammation and CNS repair. Some promising immunotherapeutic strategies have been recently developed for the treatment of CNS injury. This review updates the recent progress on elucidating the roles of the innate and adaptive immune responses in the context of CNS injury, the development and characterization of potential immunotherapeutics, as well as outstanding questions in this field.
Potential immunotherapies for traumatic brain and spinal cord injury
Creators
Raj Putatunda - Temple University
John R Bethea - Drexel University
Wen-Hui Hu - Center for Metabolic Disease Research, Department of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, 3500 N Broad Street, Philadelphia, PA, USA. Electronic address: whu@temple.edu
Publication Details
Chinese journal of traumatology, v 21(3)
Publisher
Elsevier
Grant note
R01 DK075964 / NIDDK NIH HHS
Resource Type
Journal article
Language
English
Academic Unit
Biology
Web of Science ID
WOS:000435952400001
Scopus ID
2-s2.0-85047074310
Other Identifier
991019168683404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: